CAS: 922518-84-1|4,4,5,5-tetraMethyl-2-[10-(2-phthalenyl)-9-anthracenyl]-1,3,{11} }Dioxaborolane

Taw qhia ntawm CAS: 922518-84-1|4,4,5,5-tetraMethyl-2-[10-(2-phthalenyl)-9-anthracenyl]-1,3,{11} }Dioxaborolane

Cov tshuaj "4,4,5,5-Tetramethyl-2-(10-(naphthalen-2-yl)anthracen-9-yl)-1,3 ,2-dioxaborolane" yog ib qho tshuaj anthracene uas ib pawg aryl muaj C10 lossis ntau dua yog sib koom ua ke rau 9- txoj hauj lwm thiab ib pab pawg naphthyl raug khi rau 10- txoj hauj lwm.

Lub cev thiab tshuaj lom neeg cov khoom ntawm cov tshuaj no suav nrog kev nqus GI siab, BBB permeant, thiab nws yog ib qho inhibitor ntawm CYP1A2 thiab CYP2D6. Nws muaj ib tug me ntsis soluble dej solubility.

Specification of CAS: 922518-84-1|4,4,5,5-tetraMethyl-2-[10-(2-phthalenyl)-9-anthracenyl]-1,3,{11} }Dioxaborolane

Research Application ntawmCAS: 922518-84-1|4,4,5,5-tetraMethyl-2-[10-(2-phthalenyl)-9-anthracenyl]-1,3,{11} }Dioxaborolane

Synthesis thiab Application in Drug Development

4,4,5,5-Tetramethyl-2-(10-(naphthalen-2-yl)anthracen-9-yl)-1,3,{{ 10}}dioxaborolane tau siv los ua lub tsev thaiv rau kev sib txuas cov khoom siv roj ntsha. Piv txwv li, nws tau ua lub luag haujlwm tseem ceeb hauv lwm txoj kev sib txuas ntawm cov retinoid agonist disila-bexarotene, qhia nws lub peev xwm hauv kev tsim tshuaj (Büttner li al., 2007).

Electroluminescence thiab OLED daim ntawv thov

Qhov sib xyaw no yog qhov tseem ceeb hauv kev tsim cov ntaub ntawv xiav-emitting rau cov organic teeb-emitting diodes (OLEDs). Ntau yam kev tshawb fawb tau tshawb xyuas nws cov kev siv hauv kev sib txuas cov ntaub ntawv xws li Na-AP-Na, uas nthuav tawm cov cuab yeej siv tau zoo thiab cov xim xiav xim zoo rau cov lus qhia (Lee li al., 2014). Tsis tas li ntawd, nws tau raug siv los tsim cov anthracene derivatives tshiab nrog coumarin moiety rau OLEDs, pab txhawb rau cov uas tsis yog-doped OLEDs nrog luminescence efficiency (Jung li al., 2017).

Organic Synthesis thiab Chemical Studies

Nws siv txuas mus rau cov synthesis ntawm lwm cov organic tebchaw. Piv txwv li, nws yog ib qho tseem ceeb hauv kev npaj 2-ruthenocenyl-4,4,5,5-tetramethyl-1,3-dioxa-2-borolane rau kev kawm tus cwj pwm redox ntawm binuclear ruthenocene derivatives (Sato li al., 2002). Tsis tas li ntawd, nws tau siv los tsim cov diborylated naphtho[1,{10}}c:5,6-c′]bis[1,2,5]thiadiazole, ua kom pom nws lub luag haujlwm hauv kev tsim cov khoom siv hluav taws xob zoo semiconducting polymers ( Kawashima et al., 2013).

Kev siv biochemical

Hauv kev tshawb fawb biochemical, qhov sib xyaw no tau ua haujlwm hauv kev kawm txog kev xaiv xa khoom ntawm polyamine conjugates rau hauv cov hlwb nrog cov khoom thauj khoom siv polyamine. Nws cov qauv kev hloov pauv tau raug tshawb nrhiav kom nkag siab txog cov kev txwv ntawm cov khoom siv hloov pauv raws li cov khoom thauj polyamine (Gardner li al., 2004).

Cim npe nrov: cas:922518-84-1|4,4,5,5-tetramethyl-2-[10-(2-phthalenyl)-9-anthracenyl]-1,3,{11} }dioxaborolane, Suav teb cas:922518-84-1|4,4,5,5-tetramethyl-2-[10-(2-phthalenyl)-9-anthracenyl]-1,3,{23} }dioxaborolane manufacturers, hoobkas